SCHEMBL13845543

SCHEMBL13845543

Nc1c(Br)c(N2CCCC2)nc2c(Sc3ccccc3)cnn12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.38
▸ HPGD P15428 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ PTPN11 Q06124 6/20 0.37
▸ ADORA2A P29274 3/20 0.37
▸ MAPT P10636 2/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ NUDT1 P36639 1/20 0.35
▸ NPC1 O15118 3/20 0.33
▸ RAB9A P51151 3/20 0.33
▸ CHEK1 O14757 2/20 0.33
▸ CCNA2 P20248 2/20 0.33
▸ CDK2 P24941 2/20 0.33
▸ CCNA1 P78396 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ CHRNA7 P36544 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11930850 0.85 PTPN11 (0.38) PTPN11HRH4
SCHEMBL14051055 0.82 HRH4 (0.39) HRH4
SCHEMBL14050815 0.77 TSHR (0.41) ALDH1A1HPGDPTPN11MAPTCYP1A2
SCHEMBL14545937 0.77 ADORA2A (0.42) ALDH1A1HPGDNPSR1ADORA2AMAPT
SCHEMBL11930845 0.68 CHEK1 (0.45) CHEK1CCNA2CDK2CCNA1HRH4
SCHEMBL15393818 0.66 CHEK1 (0.39) CHEK1CCNA2CDK2CCNA1HRH4
SCHEMBL11930833 0.65 HRH4 (0.47) PTPN11HRH4CSNK2A1
SCHEMBL14539517 0.64 KDR (0.38) ALDH1A1HPGDNPSR1ADORA2ACHEK1
SCHEMBL13617800 0.64 ABL1 (0.38) ALDH1A1HPGDNPSR1ADORA2AMAPT
SCHEMBL15393819 0.64 CHEK1 (0.41) CHEK1CCNA2CDK2CCNA1HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009061781-A1 NOVEL MODULATORS OF CELL CYCLE CHECKPOINTS AND THEIR USE IN COMBINATION WITH CHECKPOINT KINASE INHIBITORS SCHERING CORPORATION (US) 2009-05-14 — — WO disclosed
Send feedback